Skip to main content
. Author manuscript; available in PMC: 2016 Sep 24.
Published in final edited form as: J Med Chem. 2015 Sep 10;58(18):7485–7500. doi: 10.1021/acs.jmedchem.5b01005

Table 8.

In Vitro DMPK Profiling of Select 5-Chloropyridin-2-yl Ether Analogues

graphic file with name nihms-766653-f0016.jpg
no. R cLogPa LLEb mGlu3 IC50 (nM) fold vs mGlu5 rat plasma Fuc rat CLhep (mL/min/kg)d
99 2-cyano-5-fluorophenyl 3.29 2.99 529 >56 0.045 47.7
100 pyridin-2-yl 2.57 3.91 328 >91 0.051 69.5
101 pyridin-3-yl 2.16 4.06 608 >49 0.118 42.0
106 2-fluoropyridin-3-yl 2.67 3.74 392 >76 0.083 36.9
107 4-fluoropyridin-3-yl 2.26 4.06 482 >62 0.085 36.0
108 5-fluoropyridin-3-yl 2.26 4.06 481 >62 0.092 26.6
109 5-cyanopyridin-3-yl 1.88 4.34 605 >49 0.078 22.8
a

Calculated using Dotmatics Elemental (www.dotmatics.com/products/elemental/).

b

LLE (ligand-lipophilicity efficiency) = pIC50 – cLogP.

c

Fu = fraction unbound.

d

Predicted hepatic clearance based on intrinsic clearance in rat liver microsomes.

HHS Vulnerability Disclosure